
Botulinum therapy in urology
An effective method of treating urinary disorders.
N. Lopatkin Scientific Research Institute of Urology and Interventional Radiology (SRIUIR) contact center

- Outpatient procedure
- Long lasting effect (from 8 months)
- Multiple applications
- Payment services
N. Lopatkin Scientific Research Institute of Urology and Interventional Radiology (SRIUIR) in its practice in the treatment of patients with urinary disorders applies an effective method of outpatient treatment – botulinum therapy, which allows to increase the capacity of the bladder, get rid of cystostomies, prevent pyelonephritis, reflux, restore independent urination.
Botulinum toxin in urology
Botulinum toxin has the strongest neuroparalytic action. Its main property is to cause temporary chemodenervation of muscle structures and as a consequence – their relaxation and temporary inability to contract. This property of botulinum toxin was in demand in urological practice. The drug is used in disorders of urine accumulation (overactive bladder), bladder emptying (detrusor-sphincter dyssynergy, spastic state of the transverse urethral sphincter, decreased contractile activity of the detrusor), as well as in chronic pelvic pain syndrome and prostate adenoma. The use of botulinum toxin in the treatment of urologic diseases makes it possible to restore or improve independent urination and urinary retention, improves the quality of life of patients, and significantly helps to preserve kidney function.
What does botulinum toxin treat?
Urge and rapid urination with urge urinary incontinence. Injections are performed into the detrusor during urethrocystoscopy using an endoscopic needle. The result is partial chemodenervation of the detrusor, which is manifested by a decrease in the number of urinations per day, episodes of urge urinary incontinence. As a rule, botulinum toxin injections are performed in patients with severe forms of overactive bladder, when other methods of treatment are not effective. This type of botulinum therapy provides good treatment results in a significant number of patients with forms of overactive bladder refractory to other treatments, namely neurogenic and idiopathic detrusor overactivity.
Botulinum toxin injections are performed into the transverse urethral sphincter to partially reduce or partially eliminate functional infravesical obstruction, which is manifested by restoration of independent urination or improvement in urine flow rate. Often it is possible to save patients from the need to perform periodic autocatheterization of the bladder or permanent drainage of the bladder with a urethral catheter or cystostomy drainage. Reduction of intraurethral resistance during urination after botulinum toxin injections into the transverse striated sphincter of the urethra is the prevention of vesicoureteral reflux, which is the main cause of decreased renal function and the development of chronic renal failure. In women, the transperineal method of drug administration into the urethral transverse striated sphincter is used under electromyography control, and in men – transurethral during urethrocystoscopy.
Until recently, the arsenal of urologists for the treatment of chronic pelvic pain syndrome included non-steroidal anti-inflammatory drugs, antidepressants, myorelaxants and other drugs, often provoking a number of side effects. Prolonged, often lifelong therapy, did not always yield positive results. There are three organs in the pelvis of women: bladder, uterus and rectum. They are “suspended” on a complex system of muscles and ligaments, which works as a whole. When a muscle is in a state of constant tension, the function of the organs is disturbed. Violations manifest themselves as pain in the perineum, lower abdomen, urethra or rectum. There is a vicious circle – hypertonicity causes pain syndrome, from which the already compressed muscle is compressed even more, provoking unbearable pain. Botolotoxin injections relax the muscle and relieve the spasm. After a couple of months, new nerve endings are formed in the injection area, and the pelvic organs begin to work normally. In men, injections are performed in the prostate gland, the transverse striated sphincter of the urethra, and in the pelvic floor muscles.
Injections of botulinum toxin into the prostate gland have also started to be used for this disease. As a result of injections, the volume of adenomatous nodes is reduced, which often leads to improved or restored urination.
Methodology of the procedure
The patient is placed in the position for cystoscopy, a cystoscope is inserted, a metal inflexible needle with marks of the depth of insertion is guided through a special channel. The dilution of the drug is standard, which is specified in the technology. In the bladder is injected from 100 to 300 units of the drug, 1 ml of solution in each point. In the sphincter zone, 4 injections are performed at 3, 6, 9 and 12 hours of the conventional dial. Patients who had virtually no independent urination and who were on intermittent self-catheterization, a catheter is installed for the first 4 days, i.e., for the period of time during which the effect of botulinum toxin will begin. Habituation to the drug does not develop. Multiple use of the drug is allowed.
To decide on the possibility of botulinum therapy it is necessary to obtain a consultation at the Consultation and Diagnostic Center of the N. Lopatkin Scientific Research Institute of Urology and Interventional Radiology (SRIUIR). After the consultation it will be necessary to undergo an examination or pre-examination, after which an interdisciplinary Consilium of doctors will be held, which will decide on the chosen method of treatment. Botulinum therapy is a payment service, the price of which can be found in the price list of paid services.